IMPLEMENTING A VIRTUAL NEPHROLOGY PANEL FOR TOLVAPTAN USE IN PATIENTS WITH ADPKD

被引：0
|
作者：
Lin Duong [1 ]
Taneja, Nidhika [1 ]
Belani, Sharina [1 ]
Irannejad, Pardis [1 ]
Jain, Anagha [1 ]
Lieberman, Jonathan [1 ]
Tuan Nguyen [1 ]
Ramaswamy, Deepa [1 ]
机构：
[1] Kaiser Permanente Northern Calif, Oakland, CA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2021年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：590 / 590
页数：1
相关论文
共 50 条
  • [1] A SECONDARY ANALYSIS OF CONCURRENT USE OF METFORMIN AND TOLVAPTAN IN ADPKD TOLVAPTAN TRIALS
    Stanley, Isabelle Kitty
    Palma, Anton
    Viecelli, Andrea
    Johnson, David
    Hawley, Carmel
    Staatz, Christine
    Mallett, Andrew
    NEPHROLOGY, 2023, 28 : 81 - 81
  • [2] A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials
    Stanley, I. Kitty
    Palma, Anton M.
    Viecelli, Andrea K.
    Johnson, David W.
    Hawley, Carmel M.
    Staatz, Christine E.
    Mallett, Andrew J.
    JOURNAL OF NEPHROLOGY, 2024, 37 (5) : 1417 - 1419
  • [3] Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
    Mizuno, Hiroki
    Sekine, Akinari
    Suwabe, Tatsuya
    Ikuma, Daisuke
    Yamanouchi, Masayuki
    Hasegawa, Eiko
    Sawa, Naoki
    Ubara, Yoshifumi
    Hoshino, Junichi
    PLOS ONE, 2022, 17 (02):
  • [4] A COMPARATIVE RETROSPECTIVE STUDY OF PATIENTS WITH ADPKD: FIRST RESULTS RELATING TO THE USE OF TOLVAPTAN
    Oikonomaki, Theodora
    Liatsos, Alexandros Nikolaos
    Paikopoulou, Angeliki
    Avgikos, Dimitris
    Choulitoudi, Vasiliki
    Christodoulidou, Christallenia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I403 - I403
  • [5] Altered lipid metabolism in ADPKD patients treated with Tolvaptan
    Bargagli, Matteo
    Anderegg, Manuel
    Huynh-Do, Uyen
    Vogt, Bruno
    Ferraro, Pietro Manuel
    Fuster, Daniel
    SWISS MEDICAL WEEKLY, 2022, 152 : 16S - 16S
  • [6] DESCRIPTION OF GENETIC VARIANTS IN A COHORT OF TOLVAPTAN ADPKD PATIENTS
    Corradi, Valentina
    Caprara, Carlotta
    Pegoraro, Ofelia
    Mancini, Barbara
    Giuliani, Anna
    Gastaldon, Fiorella
    Giavarina, Davide
    Ronco, Claudio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [7] Tolvaptan in ADPKD Patients With Very Low Kidney Function
    Torres, Vicente E.
    Gansevoort, Ron T.
    Perrone, Ronald D.
    Chapman, Arlene B.
    Ouyang, John
    Lee, Jennifer
    Japes, Hina
    Nourbakhsh, Ali
    Wang, Tao
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (08): : 2171 - 2178
  • [8] URINARY LITHOGENIC RISK PROFILE IN ADPKD PATIENTS TREATED WITH TOLVAPTAN
    Bargagli, Matteo
    Dhayat, Nasser A.
    Anderegg, Manuel
    Semmo, Mariam
    Huynh-Do, Uyen
    Vogt, Bruno
    Ferraro, Pietro Manuel
    Fuster, Daniel Guido
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 12 - 12
  • [9] Urinary lithogenic risk profile in ADPKD patients treated with Tolvaptan
    Bargagli, Matteo
    Dhayat, Nasser
    Anderegg, Manuel
    Semmo, Mariam
    Huynh-Do, Uyen
    Vogt, Bruno
    Ferraro, Pietro Manuel
    Fuster, Daniel
    SWISS MEDICAL WEEKLY, 2019, : 26S - 26S
  • [10] Plasma markers of mineral metabolism in ADPKD patients treated with tolvaptan
    Bargagli, Matteo
    Dhayat, Nasser A.
    Anderegg, Manuel
    Semmo, Mariam
    Uyen Huynh-Do
    Vogt, Bruno
    Ferraro, Pietro Manuel
    Fuster, Daniel G.
    SWISS MEDICAL WEEKLY, 2020, : 22S - 22S
12345